Vanguard Group »

Sab Biotherapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $857k 276k 3.10
2024-03-31 $801k 176k 4.54